An official website of the United States government

Ravulizumab-Cwvz

PubChem Reference Collection SID
PubChem CID
Not available and might not be a discrete structure.
Synonyms
Ravulizumab-Cwvz
See also: Ravulizumab (subclass of).

1 Synonyms

Ravulizumab-Cwvz

3 Drug and Medication Information

3.1 FDA Medication Guides

Drug
Active Ingredient
RAVULIZUMAB-CWVZ
Form;Route
INJECTABLE;INJECTION
Company
ALEXION PHARM
Date
06/28/2024

3.2 FDA Approved Drugs

3.3 FDA Purple Book

Application Number
Proper Name
ravulizumab-cwvz
Status
Rx
Dosage Form
Injection; Injection
Route of Administration
Subcutaneous; Intravenous
Product Presentation
Single-Dose Cartridge; Single-Dose Vial
BLA Type
351(a)
Licensure
Licensed No. 1743
Date
December 21, 2018; June 22, 2022; October 09, 2020
Company
Alexion Pharmaceuticals, Inc.

4 Information Sources

  1. PubChem
  2. Drugs@FDA
    LICENSE
    Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.
    https://www.fda.gov/about-fda/about-website/website-policies#linking
  3. FDA Medication Guides
    LICENSE
    Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.
    https://www.fda.gov/about-fda/about-website/website-policies#linking
  4. FDA Purple Book
CONTENTS